Trial Profile
Pharmacokinetics and pharmacodynamics of edoxaban at 30-90mg in healthy Chinese volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 10 Oct 2017
Price :
$35
*
At a glance
- Drugs Edoxaban (Primary)
- Indications Atrial fibrillation; Deep vein thrombosis; Embolism; Pulmonary embolism; Stroke; Venous thromboembolism
- Focus Pharmacodynamics; Pharmacokinetics
- 10 Oct 2017 New trial record